263 related articles for article (PubMed ID: 31520523)
1. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
[TBL] [Abstract][Full Text] [Related]
2. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
3. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation.
Maeda T; Horiuchi N
J Biochem; 2009 Jun; 145(6):771-81. PubMed ID: 19254925
[TBL] [Abstract][Full Text] [Related]
5. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Hu WL; Qiao SB; Li JJ
Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
[TBL] [Abstract][Full Text] [Related]
6. Statins induce differentiation and cell death in neurons and astroglia.
März P; Otten U; Miserez AR
Glia; 2007 Jan; 55(1):1-12. PubMed ID: 16998865
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA.
Choi M; Rolle S; Rane M; Haller H; Luft FC; Kettritz R
Kidney Int; 2003 Jan; 63(1):96-106. PubMed ID: 12472772
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.
Burke JP; Watson RW; Murphy M; Docherty NG; Coffey JC; O'Connell PR
Br J Surg; 2009 May; 96(5):541-51. PubMed ID: 19358180
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts.
Madonna R; Di Napoli P; Massaro M; Grilli A; Felaco M; De Caterina A; Tang D; De Caterina R; Geng YJ
J Biol Chem; 2005 Apr; 280(14):13503-11. PubMed ID: 15705589
[TBL] [Abstract][Full Text] [Related]
10. Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's disease.
Ilg MM; Ralph DJ; Cellek S
J Sex Med; 2023 Jun; 20(7):925-934. PubMed ID: 37082866
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.
Porter KE; Turner NA; O'Regan DJ; Balmforth AJ; Ball SG
Cardiovasc Res; 2004 Mar; 61(4):745-55. PubMed ID: 14985071
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease.
Wu B; Elmariah S; Kaplan FS; Cheng G; Mohler ER
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):592-7. PubMed ID: 15618546
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
Haslinger B; Kleemann R; Toet KH; Kooistra T
Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.
Göbel A; Zinna VM; Dell'Endice S; Jaschke N; Kuhlmann JD; Wimberger P; Rachner TD
BMC Cancer; 2020 Jul; 20(1):703. PubMed ID: 32727400
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
16. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
[TBL] [Abstract][Full Text] [Related]
17. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.
Marunouchi T; Matsumura K; Fuji E; Iwamoto A; Tanonaka K
Pharmacology; 2024; 109(1):43-51. PubMed ID: 38016432
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
Meyer-Ter-Vehn T; Katzenberger B; Han H; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3955-60. PubMed ID: 18421080
[TBL] [Abstract][Full Text] [Related]
20. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
